CClinicalTrials.gg
CompletedNCT04684173Updated Sep 14, 2022

A Preliminary Study on Artificial Intelligence for Infant Motor Screening

An observational study in Motor Disorders, sponsored by National Taiwan University Hospital. Completed at 1 site in Taiwan. Open to participants aged 4 Months to 18 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-09-14.

Sponsored by National Taiwan University Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
47
Ages
4 Months to 18 Months
Sex
All
01

Study summary

The purpose of this preliminary study is to apply AI technology on a sample of infants aged 4 to 18 months to develop an action tracking and recognition algorithm for infant motor screening and to determine the accuracy of the captured movements during the Alberta Infant Motor Scale (AIMS) assessment using an experienced physical therapists' assessment results as the reference.

Read the detailed description

Background and Purpose. Although there is an increase in the public awareness of early intervention for children with developmental disorder in Taiwan, the number of children reported for early intervention by the Ministry of Health and Welfare is limited, particularly for those aged under two years, outside of hospital settings, and in remote areas. This has highlighted the need of early screening for infants who are at risk or have developmental disorders. While motor development has a potential impact on the emergence of abilities in other domains in children at later age, motor screening may serve as the cornerstone to help detect signs of developmental dysfunction. Artificial Intelligence (AI), based on machine learning of big data, may be an alternative for assisting healthcare professionals to efficiently screen children's development and to help plan for further diagnostic assessment. The purpose of this preliminary study is to apply AI technology on a sample of infants aged 4 to 18 months to develop an action tracking and recognition algorithm for infant motor screening and to determine the accuracy of the captured movements during the Alberta Infant Motor Scale (AIMS) assessment using an experienced physical therapists' assessment results as the reference. Method. This study will recruit 50 infants (40 preterm infants and 10 term infants age 4-18 months (corrected age for preterm infants) from the National Taiwan University Children's Hospital. Each infant will be evaluated by a physical therapist for their gross motor development during prone, spine, sitting and standing positions using the AIMS assessment. The whole assessment procedure will be video recorded by five cameras. The data processing of movement video records will consist of selection of movement records, establishment of a pose estimation model, and establishment of an action recognition model. The accuracy of the pose and action recognition model in identifying infants' movements will be examined using the physical therapist's results as the gold standard. The results of this study will provide preliminary data to help establish the best and appropriate action recognition model of infant motor screening for future validation on a large sample.

02

Conditions studied

  • Motor Disorders

Browse trials for

Keywords

  • AI
  • Infant
  • Motor
  • Screening
03

In context

Motor Disorders

78 studies on the registry are indexed under Motor Disorders; 26 are open to participants now.

This study's enrollment of 47 is below the median of 70 across 23 observational studies indexed under Motor Disorders.

Browse Motor Disorders studies →

Lead sponsor

National Taiwan University Hospital is the lead sponsor of 2,563 studies on the registry; 569 are open to participants now.

Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Months to 18 Months
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

The inclusion criteria for preterm infants are: gestational age \<37 weeks, birth weight \<2,500 grams, and no congenital/genetic abnormalities. Their mothers are older than 20 years of age, have no history of alcohol or drug abuse, and are married or live with fathers.

Inclusion criteria

  • The inclusion criteria for term infants are: gestational age 37-42 weeks, birth weight >2,500 grams, and no congenital/genetic abnormalities.
  • The inclusion criteria for preterm infants are: gestational age \<37 weeks, birth weight \<2,500 grams, and no congenital/genetic abnormalities.
  • Their mothers are older than 20 years of age, have no history of alcohol or drug abuse, and are married or live with fathers.

Exclusion criteria

Exclusion Criteria:

  • No
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
47 participants (actual)
Target follow-up
14 Months
Patient registry
Yes

Groups and cohorts

  • Term infants

    The inclusion criteria for term infants are: gestational age 37-42 weeks, birth weight \>2,500 grams, and no congenital/genetic abnormalities. Their mothers are older than 20 years of age, have no history of alcohol or drug abuse, and are married or live with fathers.

  • Preterm infants

    The inclusion criteria for preterm infants are: gestational age \<37 weeks, birth weight \<2,500 grams, and no congenital/genetic abnormalities. Their mothers are older than 20 years of age, have no history of alcohol or drug abuse, and are married or live with fathers.

06

What researchers measure

Primary outcomes

  1. gross motor development

    motor function in supine, prone, sitting and standing position

    Time frame: 4-18 months of age

Secondary outcomes

  1. age of walking attainment

    age of attaining independent walking for at least five steps

    Time frame: 10-18 months of age

07

Study locations

1 site
  • School and Graduate Institute of Physical Therapy, National Taiwan University
    Taipei, 100, Taiwan
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 14, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04684173
Lead sponsor
National Taiwan University Hospital
Responsible party
Sponsor
First posted
Dec 24, 2020
Start date
Nov 17, 2020
Primary completion
Mar 30, 2021
Completion
Dec 31, 2021
Last update
Sep 14, 2022

Study contacts

Suh-Fang Jeng, Professor
principal investigator · School and Graduate Institute of Physical Therapy, National Taiwan University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion